ORGOVYX™ (relugolix), the First FDA-Approved Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer, Available at Biologics by McKesson
CARY, N.C., January 19, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]
GAVRETO™ (pralsetinib), FDA Approved for Treatment of Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer, Available at Biologics by McKesson
CARY, N.C., September 17, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]
INQOVI (cedazuridine and decitabine), FDA Approved for Treatment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Available at Biologics by McKesson
CARY, N.C., August 21, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been […]
XPOVIO (selinexor), FDA Approved for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL), Available at Biologics by McKesson
CARY, N.C., June 29, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology, rare diseases and other complex therapeutic […]
Brandon Tom Appointed New General Manager of Biologics by McKesson
CARY, N.C., June 22, 2020—Biologics by McKesson, an independent specialty pharmacy and patient services company specializing in oncology, rare diseases […]
QINLOCK (Ripretinib), FDA Approved for Treatment of Gastrointestinal Stromal Tumors (GIST), Available at Biologics by McKesson
CARY, N.C., June 2, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]
RETEVMO (selpercatinib), FDA-Approved for Treatment of RET-driven Lung and Thyroid Cancers, Available at Biologics by McKesson
CARY, N.C., June 1—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected […]
Pemazyre™ (pemigatinib) Available Exclusively at Biologics by McKesson
CARY, N.C., May 27, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, will be […]
TRODELVY (sacituzumab govitecan-hziy), FDA Approved for Treatment of Metastatic Triple-negative Breast Cancer, Available Only at Biologics by McKesson
CARY, N.C., May 8, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected […]
TUKYSA (tucatinib), FDA Approved for Treatment of Advanced Unresectable or Metastatic HER2 Positive Breast Cancer, Available at Biologics by McKesson
CARY, N.C., April 17, 2020—Biologics by McKesson, an independent specialty pharmacy for oncology and other rare and complex therapeutic areas, […]